NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details Farhat Nasim27 Jun 2019 4:07 PM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Dr Reddys launches generic version of Tobi in US market Farhat Nasim26 Jun 2019 3:07 PM ISTThe product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 6:13 PM ISTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 11:59 AM ISTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
Sun pharma, Dr Reddys, others deny allegations of price fixing in US Garima16 May 2019 9:35 AM ISTIn separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit Farhat Nasim14 May 2019 4:57 PM ISTMumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
Biocon commercial rights on biosimilar adalimumab extends to global markets Farhat Nasim8 May 2019 9:45 AM ISTBiocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences Medical Dialogues Bureau8 May 2019 9:15 AM ISTYasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
Mylan, TB Alliance to commercialize Pretomanid to treat TB Farhat Nasim23 April 2019 10:00 AM ISTTB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
Prices of 21 New Drugs fixed by NPPA; Details Meghna A Singhania4 April 2019 10:00 AM ISTThe NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan Farhat Nasim13 March 2019 1:49 PM ISTValsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
Mylan launches Advair generic at 70 percent discount in US Farhat Nasim14 Feb 2019 9:15 AM ISTThe treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
